Stock Events

Stock Events

Search...

Ultragenyx Pharmaceutical (RARE) Q4 2025 Earnings

4NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-1.81

-1.6

-1.38

-1.17

Details

Expected EPS

-1.233932

Actual EPS

-1.81

Surprise EPS

-0.58

Surprise Percent

+46.69%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.81 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.